FDA approves drug for early Alzheimer’s treatment



The United States Food and Drugs Administration (FDA) approved a new drug called Leqembi on Friday that treats early Alzheimer’s by slowing the progression of the condition. Leqembi is the second …
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento